Evidence map›Paper›PMID 42630718›Full record

ArticleOncology research2026

miR-152-3p Overcomes Temozolomide Resistance in Glioblastoma by Targeting TGF-α and Enhancing Apoptosis.

Chun-Nun Chao, Chiung-Yao Fang, Chia-Hsin Hou, Jen-Tsung Yang, Yu-Ping Wu, Jui-Chieh Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chun-Nun ChaoDepartment of Pediatrics, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Chiung-Yao FangInstitute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan.
Chia-Hsin HouDepartment of Pediatrics, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Jen-Tsung YangDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Yu-Ping WuDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Jui-Chieh ChenDepartment of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsDrug Resistance, NeoplasmGlioblastomaMicroRNAsTemozolomideTransforming Growth Factor alphaAntineoplastic Agents, AlkylatingApoptosisCell Line, TumorCell SurvivalGene Expression Regulation, NeoplasticHumansPrognosisAntineoplastic Agents, AlkylatingMicroRNAsMIRN152 microRNA, humanTemozolomideTransforming Growth Factor alphadrug resistanceGlioblastoma (GBM)MiR-152-3ptemozolomide (TMZ)transforming growth factor-alpha (TGF-α)

Identifiers

PMID42630718
PMCPMC13494503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.